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Abstract 
Background: Hepatitis B is considered as one of the most common infectious diseases. The contamination of this 
virus has caused hygienic problems all over the world. Liver cirrhosis and hepatocellular carcinoma are most 
important consequences of this disease. The purpose of this study is to determine the rate of infection in Tabriz 
North West of Iran. 
Materials and Methods: This study is carried out, on partial and short time basis between 2010 and 2011, on test 
results of 21421 examined individuals whom have visited clinics in Tabriz. HBsAg of the samples was analyzed with 
chemiluminescence apparatus and finally, SPSS software was used to conduct the statistical examination of the 
results. 
Results: Among 21421 examined individuals (5021 cases in 2010 and 16400 cases in 2011), 594 samples (2.77%) 
were reported positive and 20827 samples (97.23%) were reported negative. 
Conclusion: According to the results, gender was not a determining factor affecting the susceptibility of patients. Our 
country is endemic to this disease, so diagnostic and preventive methods are crucial, more over comprehensive 
national vaccination can help to noticeably reduce the infectious cases caused by the disease. 
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Introduction 
Hepatitis B infection (HBV) is a major health problem 
and an important cause of illness and mortality. It has 
been  reported  600  thousands  death  cases,  annually 
(based on the 2012, July)1. The genome of the virus is 
DNA double strand in which one of the strands is shorter 
than the other. The antigen, HBsAg, is a soluble antigen 
which is associated with viral replication, high serum 
titration and the infection induction of serum2. HBsAg is 
 
main  antigen  of  HBV.  HBsAg  is  the  surface  antigen 
which measurable in the serum. The chronic carriers are 
the patients who their HBsAg level is stable more than six 
months despite of existence of HBsAg or Anti HBs. 
HBsAg may remain stable for several years after 
disappearing in serum. Envelop of virus is composed of 
glycoprotein  surface  antigen  (HBsAg).  Particles 
containing HBsAg could be released in the serum of 
infected individuals much more than the virions. These 
immunogenic particles can be circular or filamentous3,4.
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Radio immunoassay and ELISA test are very sensitive 
methods for displaying HBV antigens and antibodies. 
The primary diagnosis could be made based on clinical 
signs and high level of liver enzymes in blood. However, 
the serological test agianst HBV usually indicates the 
situation of the infection5. HBsAg is the first serological 
indicator which occurs in blood before the appearance of 
clinical symptoms as well as the blood of patients with 
clinical  symptoms.  Serological  indicators  plays 
significant role for diagnosis of acute HBV. Existence of 
HBsAg in serum may indicate acute or chronic infection 
or even a healthy carrier6,7. Based on the studies the 
prevalence level of disease In Iran is medium. It seems 
35% of Iranians have been exposed to the infection and 
2-3% of populations are chronically carrier. Over 50% 
of Iranian carriers have received the infection through 
mother  to  child.  Mother-child  is  one  of  the  most 
probable routs for being infected in Iran8. The different 
methods of epidemiologic tests for HBV diagnosis have 
been employed from about 30 years ago. These methods, 
including radioimmunoassay and enzyme immunoassay, 
as the molecular methods based on the nucleic acid have 
been   progressing   during   the   time9. Evolution   of 
immunity assessment methods continued with methods 
based on luminescence reactions methods10.
Given the significance of HBV infection in Iran, we 
conducted this study for determination of seroprevalence 
of Hepatitis B virus infection by quantitative 
chemiluminescent in Tabriz between 2010-2011. 
 
Methods 
The study has been accomplished cross-sectional of 
people who were attended the pathological laboratories 
of Tabriz between 2010 and 2011. The immunological 
HBsAg  of  collected  blood  samples  were  tested  by 
quantitative chemiluminescent kit (DiaSorin LIAISON®,
Turin, Italy). First a little of sample was poured to the 
cuvette by the left arm of chemiluminescent LIASSON 
(Germany),   then   the   solution   containing   magnetic 
particles   was   added   by   right   arm,   finally   it   was 
incubated. The solution was washed three times by 
washing solution buffer, and then HBsAg added to the 
cuvette. In the next step, the conjugating solution was 
added  and  was  re-incubated.  Again  the  solution  was 
washed three times and a starter solution was applied for 
measurement. First, starter 1 was poured into the vial and 
the indicator was injected to start quantitative 
chemiluminescent reactions. After about one-tenth of a 
second delay, the measurement signal was detected and 
the measurement has been completed in 3 seconds. 
Moreover, the age and the education level of patients were 
investigated by a questionnaire. The research results were 
analyzed by Chi-square test using SPSS software (version 
16). A p value of <0.05 was considered indicative of a 
statistically significant difference. 
 
Results 
From 21421 examined cases, 5021 individuals were 
examined  in  2010  and  16400  individuals  were 
examined  in  2011.  1058  (21.07%)  samples  of  2010 
were men and 3962 samples (78.93%) women. Two 
thousands three hundreds twenty four samples (14.8%) 
of 2011 were men and 14076 (85.82%) were women. 
Annual distribution of hepatitis B cases according to 
the sex is shown in table 1. 
196 and 398 samples were positive in 2010 and 2011, 
respectively. From 196 positive samples in 2010, 101 
samples were men and 95 samples were women. From 
398 positive samples in 2011, 216 were men and 182 
 
Figure 1. Prevalence of positive and negative of hepatitis B samples 
by the level of education in Tabriz, north west of Iran, 2010-2011. 
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Table 1: Annual and gender prevalence of hepatitis B cases in Tabriz, north west of Iran, 2010-2011 
No. of No. and (%) of positive samples No. and (%) of negative samples 
Years samples       
Females Males Overall Females Males Overall 
2010 5021 95 (48.47) 101 (51.53) 196 (100) 3872 (98.25) 953 (19.75) 4825 (100) 
 
2011 16400 182 (45.72) 216 (54.27) 398 (100) 13894 (86.83) 2108 (13.17) 16002 (100) 
 
Total 21421 277 317 594 17766 3061 20827 
 
Table 2: Age and gender distributions of hepatitis B cases in Tabriz, north west of Iran, 2010-2011 
No. of No. and (%) of positive samples No. and (%) of negative samples 
Years samples       
Females Males Overall Females Males Overall 
< 20 45 2 (33.33) 4 (66.66) 6 (100) 33 (84.61) 6 (15.38) 39 (100) 
 
20-29 6409 59 (45.03) 72 (54.96) 131 (100) 5274 (84.00) 1004 (15.99) 6278 (100) 
 
30-39 11638 149 (47.90) 162 (52.09) 311 (100) 9814 (86.64) 1513 (13.35) 11327 (100) 
 
40-49 2713 55 (46.21) 64 (53.78) 119 (100) 2127 (81.99) 467 (18.00) 2594 (100) 
 
≥ 50 616 12 (44.44) 15 (55.55) 27 (100) 518 (87.94) 71 (12.05) 589 (100) 
 
Total 21421 277 (46.63) 317 (53.36) 594 (100) 17766 (85.30) 3061 (14.69) 20827 (100) 
 
samples were women. Based on the result of Chi square 
test  there  is  no  significant  difference  between  the 
positive cases of men and women (α=0.05). 
The cases were aged 18–83 years (mean age 45.1 years), 
and  all  age  groups  appeared  to  be  susceptible  to 
infection. The most proportion of the cases grouped with 
the age of 30–39 years (with 2.69%). The distribution of 
hepatitis B cases in relation to the age is illustrated in 
table 2. 
The maximum age of examined individuals is 83 years 
old, the minimum age 18 years old and average is 45.1 
years old. In the women group the oldest patient 83, the 
youngest 21 and the average is 41.5 years old. The 
education   levels   of   the   infected   individuals   were: 
55.97% under graduated, 31.39% high school graduated 
and  12.62%  university  graduated.  This  study  showed 
that, the most prevalence of infection in the examined 
individuals was in under graduated (5.62%), followed by 
high school graduated with 2.26% (Figure 1). 
Discussion 
Currently, HBV is endemic in many parts of the world11,12 
and viral Hepatitis caused by HBV is a major health 
problem13-15. Liver cancer caused by Hepatitis B is one of 
the three primary deadly cancers among men and has been 
distinguished as the major cause of women cancers in 
Asian regions16-18. Over 70% of liver cancers are caused 
by HB virus. Antigen appearance of HBV infection may 
occurred without clinical signs15,19. In this study 594 cases 
(2.77%) were reported positive. 
Dan Chen carried out a similar study in the Korea and 
USA in 2004-2007 by Centaur HBsAg methods. In this 
survey 3.9% of the collected samples showed positive 
HBV infection. These finding confirmed the result of the 
present study20. Aminzadeh et al. accomplished a similar 
research  in  the  infection  ward  of  Loghman  Hakim 
hospital in Tehran cross-sectional study by detecting 
HBsAg with ELISA21. They collected the samples from 
addicted patients. The rate of positive HBsAg infection 
was reported 6% which indicated that there is a significant 
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relationship between the method of drug usage and 
positive HIV and HBsAg. These finding emphasize the 
necessity of providing facilities to quit addiction for 
addicted people of society21. Ghorbanalizadegan and et 
al. in 2006, from among 63 suspected samples, reported 
57 (90.5%) positive HBsAg samples in Baghiyatollah 
hospital with immunochemiluminescence method. 
Considering that in Ghorbanalizadegan's research all of 
the tested samples were suspected, difference between 
the results of researches is justifiable16. In a specialized 
clinic of Tehran in 2001-2003, Mohammadalizadeh and 
et al. carried out a similar study and reported the rate of 
positive HBsAg 3.3%. The results are consistent with 
the result of the present research17. Azarhoosh and et al. 
in  2006  accomplished  the  same  study in  2003.  They 
have selected 300 individuals of service, medical and 
administrative staff of five education-treatment centers 
of  Gorgan,  including  Deziyani,  Taleghani  and 
Azarshahr. The infection rate of HBsAg was reported 
1% with ELISA method. Since all of the samples were 
collected from the healthcare staff, the research results in 
comparison with the result of the present research are 
justifiable. The research result indicates that there is a 
significant relationship between HBsAg and vaccination. 
Therefore,  vaccination  is  necessary  to  prevent  HBV 
infection18.
Conclusion 
Hence,   HBV   and   HIV   spreads   in   similar   ways, 
healthcare  consideration,  accurate  and  rapid  diagnosis 
are necessary for prevention. For rapid detection of virus 
in HBV infected patients, it is suggested to apply PCR 
besides  serologic  methods.  Moreover,  increasing 
common awareness regarding the spreading methods of 
infection and vaccination are substantial actions for 
decreasing the HBV infected patients. 
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